Alternative Oxidase Inhibitors Potentiate the Activity of Atovaquone against Plasmodium falciparum
Open accessThe DOI matches its Crossref record.
Abstract
Recent evidence suggests that the malaria parasite Plasmodium falciparum utilizes a branched respiratory pathway including both a cytochrome chain and an alternative oxidase. This branched respiratory pathway model has been used as a basis for examining the mechanism of action of two antimalarial agents, atovaquone and proguanil. In polarographic assays, atovaquone immediately reduced the parasite oxygen consumption rate in a concentration-dependent manner. This is consistent with its previously described role as an inhibitor of the cytochrome bc 1 complex. Atovaquone maximally inhibited the rate of P. falciparum oxygen consumption by 73% ± 10%. At all atovaquone concentrations tested, the addition of the alternative oxidase inhibitor, salicylhydroxamic acid, resulted in a further decrease in the rate of parasite oxygen consumption. At the highest concentrations of atovaquone tested, the activities of salicylhydroxamic acid and atovaquone appear to overlap, suggesting that at these concentrations, atovaquone partially inhibits the alternative oxidase as well as the cytochrome chain. Drug interaction studies with atovaquone and salicylhydroxamic acid indicate atovaquone’s activity against P. falciparum in vitro is potentiated by this alternative oxidase inhibitor, with a sum fractional inhibitory concentration of 0.6. Propyl gallate, another alternative oxidase inhibitor, also potentiated atovaquone’s activity, with a sum fractional inhibitory concentration of 0.7. Proguanil, which potentiates atovaquone activity in vitro and in vivo, had a small effect on parasite oxygen consumption in polarographic assays when used alone or in the presence of atovaquone or salicylhydroxamic acid. This suggests that proguanil does not potentiate atovaquone by direct inhibition of either branch of the parasite respiratory chain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Genome sequence of the human malaria parasite Plasmodium falciparum
Gardner, M. J., Hall, N., Fung, E., White, O., Berriman, M., Hyman, R. W., Carlton, J. M., Pain, A., Nelson, K. E., Bowman, S., et al. (2002) · Nature · doi:10.1038/nature01097 · Cited by 4,407
Current Advances in Detection and Treatment of Babesiosis
Mosqueda, J., Olvera-Ramirez, A., Aguilar-Tipacamu, G., & Canto, G. J. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799828355 · Cited by 319
Alternative oxidase: distribution, induction, properties, structure, regulation, and functions
Rogov, A. G., Sukhanova, E. I., Uralskaya, L. A., Aliverdieva, D. A., & Zvyagilskaya, R. A. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914130112 · Cited by 73
“AOX is also found in other protozoan pathogens, such as the causative agent of tropical malaria Plasmodium falciparum [67], Philasterides dicentrarchi causing systemic disease in turbot [68], as well as in Cryptosporidium parvum, Blastocystis hominis, T.”
BackgroundThe potential of respiration inhibition as a new approach to combat human fungal pathogens
Duvenage, L., Munro, C. A., & Gourlay, C. W. (2019) · Current Genetics · doi:10.1007/s00294-019-01001-w · Cited by 52
Liu, Z., Basso, P., Hossain, S., Liston, S. D., Robbins, N., Whitesell, L., Noble, S. M., & Cowen, L. E. (2023) · Nature Communications · doi:10.1038/s41467-023-40209-w · Cited by 22
“Early-stage studies with inhibitors, either alone or in combination with inhibitorsof the ETC, have shown promise 16,18,19 .”
Metadata
- Authors
- Murphy, A. D., & Lang-Unnasch, N.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1999-03
- Volume
- 43
- Issue
- 3
- Pages
- 651-654
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2149706216
- Cited by
- 36
- References
- 0
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.